Effect and Safety of Integrative Treatment Program for Patients with Autism Spectrum Disorder: A Prospective Observational Study

Gachon University0 个研究点目标入组 50 人开始时间: 待定最近更新: 2023年8月1日

适应症

试验速览

暂无简介。

•1) Male and female children aged 12 to 30 months
•2) Those who meet the criteria for autism spectrum disorder in the DSM-5
•3) A child who has been diagnosed with autism spectrum disorder mild concern or higher on the toddler module, or autism spectrum disorder or autism on the module 2 by ADOS 2 test by a qualified clinical psychologist
•4) A person whose legal representative voluntarily signed an IRB-approved research consent form

•1) In case of accompanying neurological abnormalities (epilepsy, cerebral palsy, Down syndrome, etc.)
•2) Those diagnosed with attention deficit hyperactivity disorder, schizophrenia, etc.
•3) A person diagnosed with a serious chronic or terminal disease (malignant tumor, tuberculosis, etc.)
•4) If you are taking risperidone or aripiprazole, it has been less than 3 months since you stopped taking it
•5) If you are taking health functional food to improve autism spectrum disorder, a person who has been taking it for less than 2 weeks after stopping taking it
•6) Those who are judged unsuitable for participation in research by investigators

发起方